5.49
price up icon7.23%   0.37
after-market アフターアワーズ: 5.29 -0.20 -3.64%
loading
前日終値:
$5.12
開ける:
$4.98
24時間の取引高:
2.75M
Relative Volume:
2.38
時価総額:
$356.54M
収益:
-
当期純損益:
$-297.11M
株価収益率:
-1.0578
EPS:
-5.19
ネットキャッシュフロー:
$-216.95M
1週間 パフォーマンス:
-14.49%
1か月 パフォーマンス:
-0.54%
6か月 パフォーマンス:
-67.24%
1年 パフォーマンス:
-43.98%
1日の値動き範囲:
Value
$4.96
$6.26
1週間の範囲:
Value
$4.76
$6.89
52週間の値動き範囲:
Value
$4.07
$19.71

Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile

Name
名前
Phathom Pharmaceuticals Inc
Name
セクター
Healthcare (1161)
Name
電話
(877) 742-8466
Name
住所
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Name
職員
427
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
PHAT's Discussions on Twitter

PHAT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
PHAT
Phathom Pharmaceuticals Inc
5.49 356.54M 0 -297.11M -216.95M -5.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-14 開始されました Cantor Fitzgerald Overweight
2024-05-03 開始されました Stifel Buy
2024-01-05 繰り返されました Needham Buy
2023-08-09 開始されました H.C. Wainwright Buy
2023-05-11 アップグレード Evercore ISI In-line → Outperform
2023-03-13 開始されました Craig Hallum Buy
2022-10-21 開始されました Jefferies Buy
2022-05-06 ダウングレード Evercore ISI Outperform → In-line
2021-05-12 アップグレード Goldman Sell → Neutral
2021-02-17 開始されました BMO Capital Markets Outperform
2021-02-02 開始されました Guggenheim Buy
2020-06-26 ダウングレード Goldman Neutral → Sell
2019-11-20 開始されました Evercore ISI Outperform
2019-11-19 開始されました Goldman Neutral
2019-11-19 開始されました Jefferies Buy
2019-11-19 開始されました Needham Buy
すべてを表示

Phathom Pharmaceuticals Inc (PHAT) 最新ニュース

pulisher
01:53 AM

Critical Analysis: Quoin Pharmaceuticals (NASDAQ:QNRX) & Phathom Pharmaceuticals (NASDAQ:PHAT) - Defense World

01:53 AM
pulisher
01:28 AM

When (PHAT) Moves Investors should Listen - news.stocktradersdaily.com

01:28 AM
pulisher
Apr 01, 2025

Change at the top for Phathom as Basta replaces Curran - biocentury.com

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom's New CEO Stakes Future on Stock Price and Revenue Goals - Stock Titan

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Leadership Transition in 2025 - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals Announces Leadership Succession - MarketScreener

Apr 01, 2025
pulisher
Apr 01, 2025

Phathom Pharmaceuticals appoints new CEO - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

Strategic CEO Change: Phathom Taps Commercial Expert to Drive VOQUEZNA Market Expansion - Stock Titan

Apr 01, 2025
pulisher
Mar 31, 2025

Kenan Thompson partners with Phathom for GERD treatment By Investing.com - Investing.com Philippines

Mar 31, 2025
pulisher
Mar 31, 2025

Kenan Thompson partners with Phathom for GERD treatment - Investing.com India

Mar 31, 2025
pulisher
Mar 31, 2025

Actor and Comedian Kenan Thompson Teams Up with Phathom - GlobeNewswire

Mar 31, 2025
pulisher
Mar 31, 2025

Virtu Financial LLC Acquires New Stake in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Raymond James Financial Inc. Takes Position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 28, 2025
pulisher
Mar 28, 2025

Charles Schwab Investment Management Inc. Has $2.87 Million Holdings in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 28, 2025
pulisher
Mar 26, 2025

Bank of New York Mellon Corp Purchases 4,557 Shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) - Defense World

Mar 26, 2025
pulisher
Mar 19, 2025

Jefferies cuts Phathom Pharmaceuticals target to $13 By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 19, 2025

Jefferies Cuts Price Target on Phathom Pharmaceuticals to $13 From $17, Maintains Buy Rating - MarketScreener

Mar 19, 2025
pulisher
Mar 13, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Receives $22.17 Average Price Target from Brokerages - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Shares Purchased by Keybank National Association OH - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Phathom Pharmaceuticals stock hits 52-week low at $4.34 - Investing.com

Mar 11, 2025
pulisher
Mar 11, 2025

Phathom Pharmaceuticals stock hits 52-week low at $4.34 By Investing.com - Investing.com Australia

Mar 11, 2025
pulisher
Mar 11, 2025

Insider Buying: Asit Parikh Acquires 10,000 Shares of Phathom Ph - GuruFocus

Mar 11, 2025
pulisher
Mar 11, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT): Are Analysts Optimistic? - Simply Wall St

Mar 11, 2025
pulisher
Mar 11, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Price Target Lowered to $12.00 at The Goldman Sachs Group - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Phathom Pharmaceuticals’ Earnings Call: Growth and Challenges - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 10, 2025
pulisher
Mar 10, 2025

HC Wainwright Reaffirms “Buy” Rating for Phathom Pharmaceuticals (NASDAQ:PHAT) - The AM Reporter

Mar 10, 2025
pulisher
Mar 09, 2025

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Tops Revenue Estimates - MSN

Mar 09, 2025
pulisher
Mar 09, 2025

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Position Boosted by Rhumbline Advisers - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Phathom Pharmaceuticals’ (PHAT) “Buy” Rating Reiterated at Needham & Company LLC - The AM Reporter

Mar 09, 2025
pulisher
Mar 09, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Earns Buy Rating from HC Wainwright - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Phathom Pharmaceuticals (NASDAQ:PHAT) Earns Buy Rating from Needham & Company LLC - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Phathom Pharmaceuticals price target lowered to $12 from $18 at Goldman Sachs - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Phathom Pharmaceuticals price target lowered to $19 from $27 at Craig-Hallum - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

H.C. Wainwright maintains $28 target on Phathom Pharma stock By Investing.com - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

H.C. Wainwright maintains $28 target on Phathom Pharma stock - Investing.com

Mar 07, 2025
pulisher
Mar 07, 2025

Phathom Pharmaceuticals: Strategic Positioning and Growth Potential in GERD Market Drives Buy Rating - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Phathom Pharmaceuticals Inc (PHAT) Q4 2024 Earnings Call Highlights: FDA Approval Boosts ... - Yahoo Finance

Mar 07, 2025
pulisher
Mar 06, 2025

Phathom Pharmaceuticals Reports Strong Growth with VOQUEZNA - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Phathom Pharmaceuticals: Strong Performance and Optimistic Outlook Amidst Patent Uncertainty - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

Stifel maintains Buy on Phathom stock with $28 target - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

Stifel maintains Buy on Phathom stock with $28 target By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

Earnings call transcript: Phathom Pharma Q4 2024 sees 81% revenue rise - Investing.com UK

Mar 06, 2025
pulisher
Mar 06, 2025

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire

Mar 06, 2025
pulisher
Mar 06, 2025

Phathom Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

Phathom Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 06, 2025
pulisher
Mar 06, 2025

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewswire Inc.

Mar 06, 2025
pulisher
Mar 05, 2025

Earnings To Watch: Phathom Pharmaceuticals Inc (PHAT) Reports Q4 2024 Result - GuruFocus.com

Mar 05, 2025
pulisher
Mar 03, 2025

Phathom Pharmaceuticals stock hits 52-week low at $5.21 - Investing.com

Mar 03, 2025

Phathom Pharmaceuticals Inc (PHAT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
大文字化:     |  ボリューム (24 時間):